Patients who underwent surgery with general anesthesia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: all double-blinded randomized controlled trials that tested the efficacy of ramosetron compared with a placebo or other drug as a control in the prophylaxis of PONV
Exclusion criteria
Exclusion criteria: Studies which were reported by Fujii et al. Studies which did not include details of PON and/or POV, or the early and/or late periods. Data from case reports, comments or letters to the editor, reviews, and animal studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome from the present meta-analysis concerned PON and POV between ramosetron and ondansetron or a placebo in the early and/or late periods (defined later in this section). | — |
Countries
Japan
Contacts
Yokohama City University Graduate School of Medicine Department of Anesthesiology and Critical Care Medicine